FDA
-
-
-
-
-
-
-
Anika Therapeutics names Stephen Griffin as new CEO
-
-
-
-
-
-
-
Anika Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Anika Therapeutics (ANIK) Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
-
-
-
-
-
-
-
Anika Announces CFO Transition
-
-
-
-
-
-
-
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
-
-
-
-
-
-
-
Anika Enters Into Cooperation Agreement with Caligan Partners
-
-
-
-
-
-
-
Anika Files Preliminary Proxy Statement
-
327,362 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

